594 Appendices 752. Patel KN, Angell TE, Babiarz J, Barth NM, Blevins T, Duh QY, et al. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules. JAMA Surg. 2018;153:817-824. https:// doi.org/10.1001/jamasurg.2018.1153. 753. Schatz-Siemers N, Brandler TC, Oweity T, Sun W, Hernandez A, Levine P. Hurthle cell lesions on thyroid fine needle aspiration cytology: Molecular and histologic correlation. Diagnostic cytopathology. 2019. https://doi.org/10.1002/ dc.24247. 754. Morani F, Phadngam S, Follo C, Titone R, Aimaretti G, Galetto A, et al. PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. J Mol Endocrinol. 2014;53:247-258. https://doi. org/10.1530/JME-14-0118. 755. de Koster EJ, de Geus-Oei LF, Oyen WJG, Vriens D. In reaction to: Thuillier P, Benisvy D, Ansquer C, Corvilain B, Mirallie E, Taieb D, et al. Section 5: What is the role of functional imaging and isotopic treatment? Ann Endocrinol (Paris) 2022;83:401-6. https://doi.org/10.1016/j.ando.2022.10.008. Ann Endocrinol (Paris). 2023;84:325-326. https://doi. org/10.1016/j.ando.2022.12.002. 756. San Martin VT, Lawrence L, Bena J, Madhun NZ, Berber E, Elsheikh TM, et al. Real World Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules. The Journal of clinical endocrinology and metabolism. 2019. https://doi.org/10.1210/clinem/dgz099. 757. Kim NE, Raghunathan RS, Hughes EG, Longstaff XR, Tseng CH, Li S, et al. Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3. The Journal of clinical endocrinology and metabolism. 2023. https://doi.org/10.1210/clinem/dgad181. 758. Zhu CY, Donangelo I, Gupta D, Nguyen DT, Ochoa JE, Yeh MW, et al. Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing. The Journal of clinical endocrinology and metabolism. 2021;106:e1240-e1247. https://doi.org/10.1210/clinem/dgaa887. 759. Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. Bmj. 2008;336:1106-1110. https://doi.org/10.1136/ bmj.39500.677199.AE. 760. Siontis KC, Siontis GC, Contopoulos-Ioannidis DG, Ioannidis JP. Diagnostic tests often fail to lead to changes in patient outcomes. J Clin Epidemiol. 2014;67:612-621. https://doi.org/10.1016/j.jclinepi.2013.12.008. 761. Ferrante di Ruffano L, Davenport C, Eisinga A, Hyde C, Deeks JJ. A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. J Clin Epidemiol. 2012;65:282–287. https://doi.org/10.1016/j.jclinepi.2011.07.003. 762. Ferrante di Ruffano L, Dinnes J, Taylor-Phillips S, Davenport C, Hyde C, Deeks JJ. Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions. BMC medical research methodology. 2017;17:32. https://doi.org/10.1186/s12874-016-0286-0. 763. Tuut MK, Burgers JS, van der Weijden T, Langendam MW. Do clinical practice guidelines consider evidence about diagnostic test consequences on patient-relevant outcomes? A critical document analysis. J Eval Clin Pract. 2022;28:278-287. https://doi.org/10.1111/jep.13619. 764. Valk PE. Randomized controlled trials are not appropriate for imaging technology evaluation. Journal of nuclear medicine. 2000;41:1125-1126. 765. Lijmer JG, Bossuyt PM. Various randomized designs can be used to evaluate medical tests. J Clin Epidemiol. 2009;62:364-373. https://doi.org/10.1016/j.jclinepi.2008.06.017. 766. Van den Bruel A, Cleemput I, Aertgeerts B, Ramaekers D, Buntinx F. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. J Clin Epidemiol. 2007;60:1116-1122. https://doi.org/10.1016/j.jclinepi.2007.03.015. 767. Central Bureau for Statistics. Steeds meer hoogopgeleiden in Nederland: wat voor beroep hebben ze? 2022. https:// www.cbs.nl/nl-nl/longread/statistische-trends/2022/steeds-meer-hoogopgeleiden-in-nederland-wat-voorberoep-hebben-ze-?onepage=true. Accessed 30 November 2023. 768. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, Bossuyt PM, Deeks JJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ. 2012;344:e686. https://doi.org/10.1136/bmj.e686. 769. Cox K. Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants’ experiences. Psychooncology. 2000;9:314-322. https://doi.org/10.1002/1099-1611(200007/08)9:4<314::aidpon464>3.0.co;2-c. 770. Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007;4:e324. https://doi.org/10.1371/journal.pmed.0040324. 771. Cohen MZ, Slomka J, Pentz RD, Flamm AL, Gold D, Herbst RS, et al. Phase I participants’ views of quality of life and trial participation burdens. Support Care Cancer. 2007;15:885-890. https://doi.org/10.1007/s00520-007-0216-0. 772. Horng S, Grady C. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB. 2003;25:11-16.
RkJQdWJsaXNoZXIy MTk4NDMw